Blog
RSS FeedPosted by Michael Wonder on 06 May 2021
Australia has backed a global push to fast-track generic COVID-19 jabs
6 May 2021 - The Morrison government has joined an international push to fast-track the production of generic COVID-19 jabs, ...
Posted by Michael Wonder on 22 Apr 2021
The TGA claims Tenofovir Emtricitabine Sandoz is a first generic but is it?
22 April 2021 - Closer examination suggests otherwise. ...
Posted by Michael Wonder on 16 Apr 2021
AstraZeneca ChAdOx1-S COVID-19 vaccine
16 April 2021 - Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine. ...
Posted by Michael Wonder on 14 Apr 2021
Batch release assessment of COVID-19 vaccines
14 April 2021 - The Therapeutic Goods Administration ensures there is an independent quality assessment of every batch of vaccine supplied ...
Posted by Michael Wonder on 08 Apr 2021
‘Before end of this year’: Novavax COVID vaccine could be months away
8 April 2021 - Regulatory approvals for the third pillar of Australia’s vaccine strategy may not be obtained until the ...
Posted by Michael Wonder on 07 Apr 2021
TGA to review advertising of stem cell therapies to the Australian public
7 April 2021 - The Therapeutic Goods Administration, part of the Department of Health, is investigating the advertising of stem ...
Posted by Michael Wonder on 05 Mar 2021
New legislation to support medicine substitutions
5 March 2021 - New legislation has been passed to allow pharmacists to substitute a different medicine when a patient's ...
Posted by Michael Wonder on 05 Mar 2021
TGA adopts Access Consortium guidance for fast-tracking authorisations of modified COVID-19 vaccines for variant
5 March 2021 - TGA has adopted guidance developed by the Access Consortium - a coalition of regulatory authorities from ...
Posted by Michael Wonder on 24 Feb 2021
TGA reviewing COVID-19 tests to rule out issues diagnosing variants
24 February 2021 - Adjunct Professor John Skerritt has tasked the nation’s medical regulator with ensuring COVID-19 tests are successfully ...
Posted by Michael Wonder on 23 Feb 2021
TGA bans Pfizer, AstraZeneca brand mentions in COVID-19 vaccine advertising
24 February 2021 - Pharmacies, GPs and healthcare organisations will be banned from displaying advertisements identifying whether they are using ...
Posted by Michael Wonder on 19 Feb 2021
Clinical decision support software
18 February 2021 - From 25 February 2021, the way that software-based medical devices are regulated in Australia will change. ...
Posted by Michael Wonder on 08 Feb 2021
COVID-19 vaccine certificates to be available online within days of immunisation
8 February 2021 - Australians will have access to their COVID-19 immunisation certificates within days of receiving the vaccine, with ...
Posted by Michael Wonder on 08 Feb 2021
TGA one of only five non-European regulators invited to participate on European committees on COVID-19 vaccines and therapeutics
8 February 2021 - Australia, through the TGA, is one of only five non-European Union regulators formally invited to participate ...
Posted by Michael Wonder on 03 Feb 2021
Cost recovery implementation statement (2020-2021)
3 February 2021 - This Cost Recovery Implementation Statement provides information on how the Therapeutic Goods Administration, within the Department of ...
Posted by Michael Wonder on 02 Feb 2021
COVID‑19 vaccines – are we there yet?
1 February 2021 - The novel coronavirus SARS-CoV-2, the cause of the COVID-19 pandemic, is a highly infectious human respiratory ...